Limit search to available items
Book Cover
E-book
Author Nass, Sharyl J., author

Title Ensuring patient access to affordable cancer drugs : workshop summary / Sharyl J. Nass and Margie Patlak, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies
Published Washington, D.C. : The National Academies Press, [2014]

Copies

Description 1 online resource (1 PDF file (xx, 54 pages)) : illustrations
Contents Introduction -- new landscape of caner care -- High out-of-pocket expenses -- Migration of private practices to hospitals -- Factors influencing cancer care access and costs -- Drug shortages -- Reimbursement constraints and incentives -- 340B -- Consolidation of practices -- Potential solutions -- Patient incentives -- Physician incentives --Drug manufacturer incentives -- Wrap-up
Summary In recent years, patients' out-of-pocket costs for cancer care have been rising rapidly. These costs include health insurance deductibles, coinsurance, and copayments for covered services, as well as services that are not covered by insurance. Many cancer patients are especially vulnerable financially because their illness and/or treatment impedes their ability to work, with some patients losing employment altogether. Even with insurance, cancer patients often experience financial hardships, such as going into debt, depleting all assets to pay for cancer treatment, and personal bankruptcy. Although many elements contribute to the cost of cancer care, one important component is the cost of new cancer drugs, which has been escalating rapidly in recent years. To explore the issue of cancer drug costs and patient access to affordable, appropriate drug therapies, the Institute of Medicine's National Cancer Policy Forum convened a workshop on ensuring patient access to affordable cancer drugs in June 2014. Affordability was considered from both individual and societal perspectives. The workshop featured discussion panels as well as invited presentations from clinicians, researchers, representatives from the health insurance and pharmaceutical industries, and patient advocates. Ensuring Patient Access to Affordable Cancer Drugs summarizes the presentation and discussion of the workshop
Notes Title from PDF title page
Bibliography Includes bibliographical references
Notes This project was supported by Contract No. HHSN261200900003C between the National Academy of Sciences and the Centers for Disease Control and Prevention and by the American Association for Cancer Research, the American Cancer Society, the American Society for Radiation Oncology, the American Society of Clinical Oncology, the American Society of Hematology, the Association of American Cancer Institutes, C-Change, the CEO Roundtable on Cancer, EMD Serono, Helsinn Healthcare SA, the LIVESTRONG Foundation, the National Comprehensive Cancer Network, Novartis Oncology, the Oncology Nursing Society, and Sanofi Oncology. Additional funding for this workshop was provided by ION Solutions. The views presented in this publication do not necessarily reflect the views of the organizations or agencies that provided support for the activity
Version viewed Apr. 3, 2015
Subject Cancer -- Treatment -- Costs
Antineoplastic agents -- Costs
Drugs -- Costs
Medical care, Cost of -- United States
Health services accessibility -- United States
Neoplasms -- drug therapy
Prescription Fees
Antineoplastic Agents -- economics
Health Expenditures
Health Services Accessibility -- economics
POLITICAL SCIENCE -- Public Policy -- Social Security.
POLITICAL SCIENCE -- Public Policy -- Social Services & Welfare.
Drugs -- Costs
Health services accessibility
Medical care, Cost of
SUBJECT United States https://id.nlm.nih.gov/mesh/D014481
Subject United States
Genre/Form proceedings (reports)
Conference papers and proceedings
Conference papers and proceedings.
Actes de congrès.
Form Electronic book
Author Patlak, Margie, author
National Cancer Policy Forum (U.S.), organizer, sponsoring body.
Institute of Medicine (U.S.). Board on Health Care Services, issuing body.
ISBN 9780309312707
0309312701
9780309312714
030931271X